Literature DB >> 7240415

Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects.

P R Turner, N E Miller, C Cortese, W Hazzard, J Coltart, B Lewis.   

Abstract

The metabolism of apoprotein B-containing plasma lipoproteins by human splanchnic tissues has been studied in 29 men undergoing coronary angiography. Before catheterization autologous radio-iodinated lipoproteins were infused into a peripheral vein: 10 subjects received (125)I-labeled Sf 12-60 lipoproteins; 12 received (125)I-labeled Sf 12-60 plus (131)I-labeled Sf 100-400 lipoproteins; and 7 received (125)I-labeled Sf 12-60 plus (131)I-labeled Sf 0-12 lipoproteins. Paired arterial and hepatic vein blood samples were subsequently collected for replicate measurements of apoprotein B (apo B) mass, radioactivity and specific activity in each lipoprotein class. Splanchnic plasma flow was measured with indocyanine green. All studies were conducted after a 14-h overnight fast. Newly synthesized apo B was shown to be secreted by splanchnic tissues as a component of Sf 100-400 lipoproteins, with no detectable uptake of apo B from this class. Sf 12-60 apo B was extracted by the splanchnic bed, with no detectable secretion. After continuous intravenous infusion of (125)I-labeled Sf 12-60 for five or more hours, 41-67% (mean 55%) of extracted Sf 12-60 apo B radioactivity reappeared in hepatic vein Sf 0-12 apo B. There was no detectable splanchnic catabolism of Sf 0-12 apo B. The rates of Sf 100-400 apo B secretion, calculated as the product of artery-hepatic vein concentration difference and splanchnic plasma flow, were greater than the previously reported rates of very low density lipoprotein apo B turnover in fed subjects obtained by kinetic analysis of plasma specific radioactivity decay curves, suggesting that there may be a diurnal variation in hepatic apo B synthesis. They also exceeded the splanchnic extraction rates of Sf 12-60 apo B, suggesting there was some extrasplanchnic catabolism of the apo B of Sf > 60 lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240415      PMCID: PMC370744          DOI: 10.1172/jci110205

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Biosynthetic determination with radioactive sulfur of turn-over rates of various plasma proteins in normal and cirrhotic man.

Authors:  W VOLWILER; P D GOLDSWORTHY; M P MACMARTIN; P A WOOD; I R MACKAY; K FREMONT-SMITH
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

2.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

4.  On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein.

Authors:  S Eisenberg; D W Bilheimer; R I Levy; F T Lindgren
Journal:  Biochim Biophys Acta       Date:  1973-12-20

5.  Splanchnic secretion rates of plasma triglycerides and total and splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia.

Authors:  J Boberg; L A Carlson; U Freyschuss; B W Lassers; M L Wahlqvist
Journal:  Eur J Clin Invest       Date:  1972-11       Impact factor: 4.686

6.  The characterization of a discrete series of low density lipoproteins in the disease, hyper-pre-beta-lipoproteinemia. Implications relating to the structure of plasma lipoproteins.

Authors:  M G Hammond; W R Fisher
Journal:  J Biol Chem       Date:  1971-09-10       Impact factor: 5.157

7.  Interaction of rat plasma very low density lipoprotein with lipoprotein lipase-rich (postheparin) plasma.

Authors:  S Eisenberg; D Rachmilewitz
Journal:  J Lipid Res       Date:  1975-09       Impact factor: 5.922

8.  The metabolic conversion of very-low-density lipoprotein into low-density lipoprotein by the extrahepatic tissues of the rat.

Authors:  B S Suri; M E Targ; D S Robinson
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

9.  Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia.

Authors:  E D Janus; A Nicoll; R Wootton; P R Turner; P J Magill; B Lewis
Journal:  Eur J Clin Invest       Date:  1980-04       Impact factor: 4.686

10.  Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons.

Authors:  T G Redgrave
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  9 in total

Review 1.  The lipoproteins: predictors, protectors, and pathogens.

Authors:  B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

2.  Inhibition of cholesterol synthesis reduces low-density-lipoprotein apoprotein B production without decreasing very-low-density-lipoprotein apoprotein B synthesis in rabbits.

Authors:  A La Ville; R Moshy; P R Turner; N E Miller; B Lewis
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

Review 3.  Very low density lipoprotein apolipoprotein B metabolism in humans.

Authors:  T Demant; J Shepherd; C J Packard
Journal:  Klin Wochenschr       Date:  1988-08-15

4.  Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.

Authors:  A Rubinstein; J C Gibson; J R Paterniti; G Kakis; A Little; H N Ginsberg; W V Brown
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

5.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

6.  Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey.

Authors:  I J Goldberg; N A Le; J R Paterniti; H N Ginsberg; F T Lindgren; W V Brown
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

7.  Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.

Authors:  W F Beltz; Y A Kesäniemi; B V Howard; S M Grundy
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 8.  Hyperlipoproteinemia type 3: the forgotten phenotype.

Authors:  Paul N Hopkins; Eliot A Brinton; M Nazeem Nanjee
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

9.  Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family.

Authors:  J H Auwerx; S P Babirak; J E Hokanson; G Stahnke; H Will; S S Deeb; J D Brunzell
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.